PROPANC BIOPHARMA REPORTS PRECLINICAL DATA WITH PRP & PRP PLUS TGF-Β INHIBITOR ON TGF-Β PATHWAY IN PANCREATIC CANCER

Reuters · 11/02 13:30

Please log in to view news